Intensity Therapeutics, Inc. (private), developing novel immune based drug products to treat cancer, announced that President and CEO Lewis H. Bender has been invited to give a talk at the 10th Annual Value-Based Oncology Management Forum on Wednesday, October 14, 2015 at 4:00 PM in the Warwick Allerton Hotel in Chicago Illinois. Mr. Bender’s presentation is titled; Immuno-Oncology (IO) Beyond PD-1 Combinations – The Potential Next Generation of Immuno-Oncology. The talk will examine

• the current commercial IO products, products in the pipeline, and combination products,
• discuss the cancers where IO products have been successful and those indications where these drugs have been less than successful,
• a new, emerging science that may make IO work more effectively; and
• potential next generation immune system based products.